ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 66 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,157 | +290.7% | 10,458 | +363.2% | 0.00% | – |
| Q2 2023 | $2,088 | +59.6% | 2,258 | +88.2% | 0.00% | – |
| Q1 2023 | $1,308 | -34.6% | 1,200 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | +100.0% | 1,200 | -4.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 1,250 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 1,250 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 1,250 | +19.0% | 0.00% | – |
| Q3 2021 | $5,000 | – | 1,050 | +2000.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 50 | -99.6% | 0.00% | – |
| Q3 2020 | $101,000 | +3266.7% | 12,676 | +1167.6% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |